TrueBlue (TBI) News
NYSE: TBIConsumer DiscretionaryProfessional ServicesUSD
8.87-0.29 (-3.17%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
TBI news summary
We found 4 recent headlines mentioning TrueBlue (TBI): 0 in the past week and 3 in the past 30 days, most often from Nasdaq. For price context, TBI is down 3.17% at $8.87. The most recent story, "Here's Why Investors Should Hold EFX Stock in Their Portfolios Now", was published by Nasdaq on Sep 18, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest TrueBlue headlines
- Here's Why Investors Should Hold EFX Stock in Their Portfolios NowEquifax's growth outlook is backed by Workforce Solutions demand, AI-driven products and savings and broad-based international revenue gains.NasdaqEFX, TBI, TT
- Advisory Expertise & Specialized Talent Aid CRAI Amid Stiff RivalryCharles River benefits from rising advisory demand, a strong talent base and capital returns. Its competition and higher talent costs pressure margins.NasdaqCRAI, TBI, TT
- Broad-Based Demand & Talent Investments Aid FCN Amid Stiff RivalryFTI Consulting gains from broad-based demand, talent investments, solid liquidity and buybacks, but competition and no dividend weigh on appeal.NasdaqFCN, TBI, TT
- Here's Why Investors Must Hold WCN Stock in Their Portfolios NowWaste Connections gains as market expansion, acquisitions and steady dividends support growth despite rising liquidity and regulatory pressures.NasdaqWCN, TBI, VNT